Semaglutide is a peptide that acts as a GLP-1 agonist, similar to the other therapies in this list. It is being studied for its potential neuroprotective properties, aiming to reduce neuroinflammation and oxidative stress in Parkinson’s disease and thereby slow disease progression.
Discover our Products
Science-based and high-quality devices
